Autoimmune diseases treatment

Towards improved immunotherapy

harminka — Mon, 01 Dec 2008 15:14:27 -0600

A study (doi:10.1016/j.clim.2008.07.027) published by Elsevier this month in Clinical Immunology, the official journal of the Clinical Immunology Society (CIS), describes a new method that facilitates the induction of a specific type of immune suppressive cells, called 'regulatory T cells' for therapeutic use.

Step toward more targeted treatment for auto-immune diseases

harminka — Mon, 28 Jan 2008 05:54:41 -0600

More and more people in Western society are suffering from autoimmune diseases. Discovering the cause of these chronic inflammations is a first important step in the search for targeted medicines. VIB researchers connected to Ghent University and the Katholieke Universiteit Leuven joined forces and have elucidated the function of MALT1, a key player in controlling inflammatory reactions.

Possible key to autoimmune disease

harminka — Sun, 16 Sep 2007 15:10:36 -0500

A human peptide that acts as a natural antibiotic against invading microbes can also bind to the body’s own DNA and trigger an immune response in the absence of an infection, a research team led by scientists at The University of Texas M. D. Anderson Cancer Center reports in an early online publication in Nature.

Potential role for retinoic acid in autoimmune, inflammatory diseases

harminka — Wed, 20 Jun 2007 07:45:40 -0500

An important finding, which could eventually lead to a new therapeutic approach for treating autoimmune and inflammatory diseases such as rheumatoid arthritis, colitis, psoriasis and others, was announced today by researchers at the La Jolla Institute for Allergy & Immunology (LIAI).

Autoantibodies help T cells "see" their target

harminka — Sat, 21 Apr 2007 06:59:51 -0500

Autoimmune diseases such as type I diabetes and rheumatoid arthritis are caused by the immune system attacking the body's own tissues. Determining the factors that trigger the immune system to attack is an area of intensive research.